TD Cowen Sticks to Its Buy Rating for Sarepta Therapeutics (SRPT)
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price ...
Mizuho Securities Remains a Hold on Revance Therapeutics (RVNC)
Mizuho Securities analyst Uy Ear maintained a Hold rating on Revance Therapeutics (RVNC – Research Report) yesterday and set a price target of ...
Yahoo Finance16h
Arrowhead Pharmaceuticals, Inc. (ARWR)
Needham thinks the deal makes strategic sense given Sarepta’s ex Sarepta Therapeutics (SRPT), the leader in precision genetic medicine for rare diseases announced an exclusive global licensing ...
KTBS16h
Smoke detectors alert Sarepta woman to house fire
SAREPTA, La. -- Working smoke detectors get the credit for a woman surviving a fire in her home Monday night. A woman who ...